Schedule 13D ownership disclosure

EYEGATE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 30233M107

Event date: 2017-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,045,279
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-000215
Form type
SC 13D/A
Filer
KIORA PHARMACEUTICALS INC
CIK
CIK 1372514
Filed
Jan 02, 2018
Reporting period
Dec 29, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub